...BRCA2 mutation carriers (HR=1.05, 95% CI 0.63-1.59 and HR=1.81, 95% CI 1.14-2.78, respectively). Our analysis suggests s...
...BRCA2 mutation to a patient who was diagnosed at age 40 with locally advanced breast and pancreas cancer is presented. S...
...BRCA2, ATM, PALB2, and other DNA repair genes.We review the current evidence of how this strategy is relevant for the tr...
...BRCA2 mutation carriers have worse BCSS than sporadic/BRCA-negative cases (HR 1.29, 95% CI: 1.03-1.62), although they ha...
...BRCA2 (FANCD1) and SLX4 (FANCP) accumulation on the sex chromosomes during meiosis. In addition, FA proteins modulate di...
...BRCA2. As human RAD51 has proved impossible to produce in a form that is compatible with the requirements of fragment-ba...
BRCA2 is a multifunctional tumor suppressor involved in homologous recombination (HR), mitotic checkpoint regulation, an...
...BRCA2 deleterious mutation. BRCA1 ASE evaluated on three SNPs among controls and HBOC patients without deleterious mutat...
...BRCA2) in 190 breast cancer patients with a strong family history of breast cancer. These women had previously tested ne...
...BRCA2), pathogenesis (BRAF, NRAS, PIK3CA, KIT, PTEN), skin/hair pigmentation (MC1R, MITF) and in immune pathways (CTLA4)...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
